These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3917651)

  • 1. [Clinical study on the permeability of FT-207 and 5-FU in primary lung cancer].
    Aogauchi R; Tsubota N; Yamashita C; Yoshikawa K; Ishii N; Nakamura K
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):105-10. PubMed ID: 3917651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pre- and intra-operative chemotherapy using FT-207 suppositories--with special reference to lung cancer].
    Fukuda K; Komatubara S; Sato G; Teramoto S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2212-5. PubMed ID: 6307181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT].
    Oiwa T; Saito H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):525-30. PubMed ID: 3082289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of serum and tissue concentrations of FT-207 and 5-FU in patients with cancer of the large intestine following preoperative application of FT-207 suppositories].
    Okuda M; Teramoto T; Yoshida H; Sato K; Ushijima Y; Uematsu Y
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1580-8. PubMed ID: 6820920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum and tissue concentration of tegafur and 5-FU after administration of tegafur suppository in patients with lung cancer--correcting the influence of residual blood in the tissue].
    Ohno K; Nakahara K; Hashimoto J; Matsumura A; Mizuta T; Akashi A; Nakagawa K; Takeda S; Minami M; Kawashima Y
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3603-8. PubMed ID: 2510605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [UFT in the treatment of primary lung cancer--5-FU concentration in the tissue and side effects].
    Kato H; Inoue S; Takahashi K; Yamanaka A; Okada Y
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1866-70. PubMed ID: 3036016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [FT-207 and 5-FU concentrations in brain tumor tissues, plasma and CSF after administration of FT-207 suppository].
    Matsuura H; Nakazawa S
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):912-6. PubMed ID: 6426399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of FT-207 rectum suppository in squamous cell carcinoma of the uterine cervix. (II) Pharmacokinetics in continuous administration at a daily dose of 1 gram].
    Okazaki H; Hasegawa T; Endoh S; Hayashi Y; Chin N; Rin K; Nakagiri Y; Ishii Y; Fukui H; Kohno I
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):848-52. PubMed ID: 6426396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after administration of FT-207 suppositories].
    Kumazawa H; Imai N; Shioya M; Kato K; Fukaya Y; Noguchi A
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1655-62. PubMed ID: 6433799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of intravenous administration of FT-207 for gastric cancer].
    Otani Y; Yamanaka T; Kikuchi H; Namatame K; Yoshida K; Kataba Y; Maruyama Y; Watanabe H
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):857-60. PubMed ID: 3920970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of tissue concentrations of FT-207 and 5-FU in head and neck cancer].
    Fukuyo K; Eura S; Nagano H; Kato T; Soda T
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):967-72. PubMed ID: 6408992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of chemotherapy of breast cancer (2). Clinical evaluation of the blood and tissue concentrations of FT-207 following intrarectal administration].
    Hiraide H; Mimura K; Kawano M; Hatsuse K; Kadota T; Kurokawa T; Tamaki K; Kanabe S; Mizoguchi O; Terashima H; Iwasa H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):992-6. PubMed ID: 6408994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum concentration of 5-FU and tegafur (FT-207) after administration of tegafur (FT-207) suppository with the colostomy].
    Kimoto M; Nagano H; Gunge N; Murei T; Iwamoto S; Seo Y; Yamamoto Y; Sano K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2853-8. PubMed ID: 3116942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of FT-207 rectum suppository in squamous cell carcinoma of the uterine cervix. (I) Pharmacokinetics in single administration at a dose of 1 gram].
    Okazaki H; Hasegawa T; Fujimori T; Katayama S; Sakaguchi K; Hayashi Y; Nakagiri Y; Ishii Y; Fukui H; Kohno I
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):840-7. PubMed ID: 6426395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of pre-operative chemotherapy using FT-207 suppositories combined with glutathione--with special reference to histopathological antitumor effect].
    Kaga F; Kitajima M; Ikeda Y; Seki M; Yagita A; Sohma S; Fukuzumi N
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):489-95. PubMed ID: 6820899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of intravenous feeding on adjuvant chemotherapy--an experimental study on the distribution of 5-FU after injection of tegafur (1)].
    Kimoto M; Nagano H; Sano K
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):135-9. PubMed ID: 3099649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
    Takeshita M; Ishikawa H; Seki M; Ikeya T; Miyamoto Y; Izuo M; Tozuka S; Usui R; Kaneko H
    Gan No Rinsho; 1985 Oct; 31(13):1697-703. PubMed ID: 3935831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The concentration of 5-fluorouracil in blood and tissues of the patients with carcinoma of the cervix after administration of UFT and 5-fluorouracil].
    Yamashita K; Mitani K; Morishita Y; Inoue K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):767-73. PubMed ID: 2496666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative treatment of FT-207 suppository in cervical cancer-- serum and tumor tissue content of FT-207].
    Nagai S; Sawada T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):307-11. PubMed ID: 6421248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of Tegafur suppository in the treatment of uterine cancer--with special reference to the drug concentration in the blood, secretion from the pelvic dead space, and tissues of female genital organs].
    Yamada E
    Igaku Kenkyu; 1982 Nov; 52(5):269-87. PubMed ID: 6821182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.